about
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and i...
Read More
0.79
-0.09
(-10.23%)
2.8M
XNAS Volume
High vol.+loss this week
XNAS 08 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Palisade Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..